Jump to main content
Jump to site search


Heterocyclic Schiff base transition metal complexes in antimicrobial and anticancer chemotherapy

Author affiliations

Abstract

In recent years, the number of people suffering from cancer and multidrug-resistant infections has sharply increased, leaving humanity without any choice but to search for new treatment options and strategies. Although cancer is considered the leading cause of death worldwide, it also paves the way many microbial infections and thus increases this burden manifold. Development of small molecules as anticancer and anti-microbial agents has great potential and a plethora of drugs are already available to combat these diseases. However, the wide occurrence of multidrug resistance in both cancer and microbial infections necessitates the development of new and potential molecules with desired properties that could circumvent the multidrug resistance problem. A successful strategy in anticancer chemotherapy has been the use of metallo-drugs and this strategy has the potential to be used for treating multidrug-resistant infections more efficiently. As a class of molecules, Schiff bases have been the topic of considerable interest, owing to their versatile metal chelating properties, inherent biological activities and flexibility to modify the structure to fine-tune it for a particular biological application. Schiff base-based metallo-drugs are being researched to develop new anticancer and anti-microbial chemotherapies and because both anticancer and anti-microbial targets are different, heterocyclic Schiff bases can be structurally modified to achieve the desired molecule, targeting a particular disease. In this review, we collect the most recent and relevant literature concerning the synthesis of heterocyclic Schiff base metal complexes as anticancer and anti-microbial agents and discuss the potential and future of this class of metallo-drugs as either anticancer or anti-microbial agents.

Graphical abstract: Heterocyclic Schiff base transition metal complexes in antimicrobial and anticancer chemotherapy

Back to tab navigation

Publication details

The article was received on 16 Oct 2017, accepted on 05 Dec 2017 and first published on 06 Dec 2017


Article type: Review Article
DOI: 10.1039/C7MD00526A
Citation: Med. Chem. Commun., 2018, Advance Article
  •   Request permissions

    Heterocyclic Schiff base transition metal complexes in antimicrobial and anticancer chemotherapy

    M. A. Malik, O. A. Dar, P. Gull, M. Y. Wani and A. A. Hashmi, Med. Chem. Commun., 2018, Advance Article , DOI: 10.1039/C7MD00526A

Search articles by author

Spotlight

Advertisements